Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel, proprietary ...

Galera Therapeutics (OTC:GRTX), Inc. (OTC Pink Market:GRTX) held a Special Meeting of Stockholders on Thursday, where attendees voted against the proposed liquidation and dissolution of the company.

Galera Therapeutics (OTC:GRTX), Inc. (OTC Pink Market:GRTX) held a Special Meeting of Stockholders on Thursday, where attendees voted against the proposed liquidation and dissolution of the company.